Pharmenable Therapeutics Limited
10430444
Healthy
No risk factors detected.
Details
Compliance
Accounts
Confirmation statement
Industry
Officers
director · Since 17/10/2016
DIRECTOR
BRITISH · ENGLAND · Age 48
Also on 2 other boards
director · Since 11/12/2019
DIRECTOR
BRITISH · UNITED KINGDOM · Age 63
Also on 5 other boards
director · Since 18/11/2022
VENTURE CAPITALIST
CANADIAN · UNITED STATES · Age 60
Persons with Significant Control
Former PSCs
Dr Hannah Fiona Sore
Ceased 01/05/2020
Dr Natalie Mateu
Ceased 01/05/2020
CompanyRankvs 297080+ SIC 74909 peers54
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/01/2026
Net Worth
£32
Balance sheet strength
Cash
£719k
Cash in the bank
Net Current Assets
£840k
Working capital
Current Assets
£963k
Current Liabilities
£123k
Fixed Assets
£3k
Debtors
£244k
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2026 | 7.80 | — |
| 2026 | 7.80 | — |
| 2025 | 12.41 | — |
| 2024 | 25.04 | — |
| 2023 | 47.79 | +£3.4M |
| 2022 | 23.19 | -£611k |
| 2021 | 53.35 | — |
| 2020 | 0.82 | — |
| 2019 | 1.20 | — |
Derived from filed accounts. Not audited figures.